Mizuho Medy Co (TSE:4595) Total Equity: 円18,683 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4595 Mizuho Medy Co Ltd TSE:4595
84 GF Score
Price 円1,662.00
GF Value 円1,440.52
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Mizuho Medy Co Total Equity?

Mizuho Medy Co TSE:4595 +0.12% 84 Total Equity is 円18,683 Mil as of Dec. 2025. GuruFocus rates TSE:4595 with a GF Score™ of 84/100 and a GF Value™ of 円1,440.52 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Mizuho Medy Co's total equity for the quarter that ended in Dec. 2025 was 円18,683 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Mizuho Medy Co Total Equity Historical Data

* Premium members only.

The historical data trend for Mizuho Medy Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mizuho Medy Co Total Equity Chart

Mizuho Medy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,028.64 14,282.70 15,674.00 17,352.00 18,683.00

Mizuho Medy Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,987.00 17,230.00 16,846.00 18,683.00 18,332.00
TSE:4595
84GF Score
Mizuho Medy Co Ltd TSE:4595
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mizuho Medy Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Mizuho Medy Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=22375-3692
=18,683

Mizuho Medy Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=22375-3692
=18,683

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円18,683 Mil mean?
Mizuho Medy Co (TSE:4595) has a Total Equity of 円18,683 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Mizuho Medy Co and its competitors.
Is Mizuho Medy Co's Total Equity too high?
Mizuho Medy Co's current Total Equity is 円18,683 Mil. Overall, Mizuho Medy Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mizuho Medy Co's Total Equity compare to ZTS and UTHR?
Mizuho Medy Co's Total Equity of 円18,683 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Mizuho Medy Co and its competitors. Mizuho Medy Co's current Total Equity is 円18,683 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mizuho Medy Co stock overvalued right now?
Based on GuruFocus' analysis, Mizuho Medy Co (TSE:4595) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,440.52, compared to a current price of 円1,662.00 — trading 15.4% above its estimated fair value. The current Total Equity is 円18,683 Mil. Mizuho Medy Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Mizuho Medy Co (TSE:4595), the current Total Equity is 円18,683 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mizuho Medy Co (TSE:4595) Overvalued in 2026?

Based on GuruFocus' analysis, Mizuho Medy Co stock appears to be overvalued. The current stock price of 円1,662.00 is trading 15.4% above its estimated GF Value™ of 円1,440.52. GuruFocus considers Mizuho Medy Co to be Modestly Overvalued.

Key valuation signals for TSE:4595:

  • Total Equity: 円18,683 Mil
  • GF Value™: 円1,440.52 vs. price of 円1,662.00 (15.4% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the TSE:4595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mizuho Medy Co Business Description

Address 5-4 Fujinoki-machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture, and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including a digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
84GF Score

Get the complete analysis for TSE:4595

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,662.00
Price
円1,440.52
GF Value